– Developed in collaboration with Janssen, the Single Cell resource is being made available on the nferX® platform for free to academic researchers worldwide – – Announcement follows nference joining the COVID-19 Healthcare Coalition, a private sector collaborative with Mayo Clinic, MIT Faculty and Health IT leaders, coordinated by MITRE – nference today announced the launch of a first-in-class software […]
Lausanne, Switzerland, and Boston, United States: SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering the benefits of this solution to […]
SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division […]
Grant of $1 million used to finalize development and deployment of existing assay to triage coronavirus patients Toronto, Ontario, SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”), has been selected by University Health Network (“UHN”) investigators to […]
VIENNA, AUSTRIA, MARCH 24, 2020 – Lexogen is pleased to announce the appointment of Intra Globus Biosystems Pvt. Ltd (IGB) as its official distributor in India, as a further step in growing its operations in the APAC region. IGB, a subsidiary of Integrated Gulf Biosystems LLC, is a well-established organization headquartered in Dubai, UAE, with a reputation of […]
The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19. The resulting data will help deliver insights into how the virus is transmitted and how it evolves. Oxford Nanopore is delighted to support participating teams across the UK in this project, including […]
Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass. — For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug products, Thermo Fisher Scientific is investing more than $475 million in new capabilities and […]
After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences (“PacBio”) in this litigation. During the trial, the jury heard evidence that PacBio had never performed nanopore sequencing, before or after they filed patents that allegedly cover nanopore […]
HAYWARD, Calif., — Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today announced availability of its CleanPlex® SARS-CoV-2 Panel for COVID-19 coronavirus detection, tracking and research via amplicon-based target enrichment for NGS applications. The highly multiplexed target enrichment panel covers the entire genome of the SARS-CoV-2 virus […]
FARMINGTON, Conn.— Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, recently unveiled a convenient new solution for the generation of 16S and StrainID amplicons The Shoreline Waveamplicon kit contains the same innovative amplification capabilities as the Shoreline Complete kit. It is a convenient solution for […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
